CTNNB1 and hepatoblastoma: In hepatoblastoma, CTNNB1 mutations have been found in up to 67% of cases, all affecting exon 3 which encodes the degradation targeting box of β-catenin, resulting in nuclear β-catenin accumulation [29–31].